Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$2.50
+1.2%
$2.44
$1.91
$48.79
$7.97M7.7953,077 shs43,603 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
+1.21%+15.21%+17.65%-44.57%-77.27%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$13.80M0.59N/AN/A$0.22 per share11.36

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$13.58M-$10.93N/AN/A-117.06%-1,879.30%-126.83%8/21/2024 (Estimated)

Latest VVOS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2024Q1 2024
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/A-$1.63-$1.63-$1.63N/A$3.42 million
3/28/2024Q4 2023
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/A-$3.05-$3.05-$3.05N/A$3.25 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/A
0.45
0.45

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
26.35%

Insider Ownership

CompanyInsider Ownership
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
9.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
1143.23 million2.92 millionOptionable

VVOS Headlines

Recent News About These Companies

Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Vivos Therapeutics logo

Vivos Therapeutics

NASDAQ:VVOS
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.